浙江华康药业股份有限公司2025 年半年度报告摘要 浙江华康药业股份有限公司 公司代码：605077 公司简称：华康股份 浙江华康药业股份有限公司2025 年半年度报告摘要 第一节 重要提示 展规划，投资者应当到 http://www.sse.com.cn/网站仔细阅读半年度报告全文。 第二节 公司基本情况 公司股票简况 | 股票种类 股票上市交易所 | | 股票简称 股票代码 | | 变更前股票简称 | | --- | --- | --- | --- | --- | | A股 | 上海证券交易所 | 华康股份 605077 | 不适用 | | | 联系人和联系方式 | 董事会秘书 | | 证券事务代表 | | | 姓名 | 吴志平 | 柳强 | | | | 电话 | 0570-6035901 | 0570-6035901 | | | | 办公地址 | 浙江省开化县华埠镇华工路18号 | | 浙江省开化县华埠镇华工路18号 | | | 电子信箱 | zqb@huakangpharma.com | zqb@huakangpharma.com | | | | | | 单位：元 币种：人民币 | | | | | | ...

Group 1 - The latest stock price of Huakang Co., Ltd. is 18.05 yuan, up 0.39% from the previous trading day, with a trading volume of 24,473 hands and a transaction amount of 44 million yuan [1] - The company has a total market capitalization of 5.47 billion yuan and a price-to-earnings ratio of 16.87 times [1] - Huakang Co., Ltd. operates in the food and beverage sector, focusing on the research and production of functional sugar alcohols, starch sugars, and health food ingredients [1] Group 2 - On August 6, the company disclosed the institutional research records from July 1, with 10 institutions including Guosen Securities and Southern Fund participating, focusing on the development of the company's sugar alcohol business [1] - This marks the 95th institutional research activity for the company in the past year [1] - On August 6, the net outflow of main funds was 3.41 million yuan, with a cumulative net outflow of 10.03 million yuan over the past five trading days [1]